Pritzker Private Capital, a leader in family direct investing, today announced the appointment of Paula Stafford to the Pritzker advisory board. Stafford is currently chairman and CEO of biotechnology company Novan.
Chaired by Tony Pritzker, the Pritzker advisory board is a team of eight strategic and operational executives. PAB members advise on PPC’s investment strategy, strengthen partnerships with management teams and enhance the firm’s operations capabilities.
“We are pleased to welcome Paula to the Pritzker Advisory Board and the PPC family,” said Michael Dal Bello, investment partner, healthcare at PPC and co-leader of PPC’s healthcare team. “Paula is a globally recognized leader in the pharmaceutical industry with a proven track record of growth and success. Her deep expertise and strong relationships across the sector will help us continue to identify exciting new partnership opportunities and expand our family of healthcare companies.”
“Paula is a great addition to the Pritzker Advisory Board. Her unique experience, growth mindset and history of value creation will strengthen the operations capabilities PPC provides to its companies,” said David King, operating partner – Healthcare at PPC and co-leader of PPC’s Healthcare team. “At PPC, we believe in building businesses for the long term, and I look forward to working closely with Paula as we build value across our family of companies.”
“I am delighted to join the accomplished group of executives that make up the Pritzker Advisory Board,” said Stafford. “I have long admired PPC’s philosophy, culture and the remarkable Pritzker legacy. I am eager to contribute to the PPC team, identifying new companies that are a compelling fit with PPC’s values and partnering with strong management teams to support their long-term growth.”